Charles V Pollack Selected Research

Anticoagulation Reversal

10/2020	Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel.
1/2020	A review of guidelines on anticoagulation reversal across different clinical scenarios - Is there a general consensus?
5/2017	Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles V Pollack Research Topics

Disease

56	Hemorrhage 01/2021 - 06/2006
55	Acute Coronary Syndrome 03/2021 - 11/2002
21	ST Elevation Myocardial Infarction 03/2021 - 01/2004
20	Myocardial Infarction 10/2020 - 03/2003
13	Unstable Angina 02/2020 - 09/2005
12	Thrombosis (Thrombus) 01/2021 - 01/2003
12	Non-ST Elevated Myocardial Infarction 12/2020 - 11/2003
12	Stroke (Strokes) 10/2020 - 11/2005
9	Heart Failure 10/2020 - 05/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2002
7	Asthma (Bronchial Asthma) 01/2016 - 08/2002
6	Atrial Fibrillation 01/2019 - 09/2013
6	Hypertension (High Blood Pressure) 10/2011 - 07/2006
5	Venous Thromboembolism 01/2019 - 11/2012
5	Ischemia 12/2009 - 12/2006
5	Chest Pain (Chest Pains) 12/2006 - 01/2004
4	Necrosis 02/2020 - 04/2005
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2020 - 09/2006
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 03/2014
4	Wounds and Injuries (Trauma) 04/2016 - 11/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 06/2011
3	Pain (Aches) 01/2021 - 01/2015
2	Acute Pain 01/2021 - 03/2016
2	Infections 01/2020 - 04/2015
2	Ischemic Stroke 04/2016 - 01/2003
2	Musculoskeletal Pain 10/2015 - 01/2015
2	Hematoma 08/2014 - 12/2009
2	Pulmonary Embolism 09/2013 - 11/2012
2	Chronic Renal Insufficiency 03/2009 - 03/2008
2	Infarction (Infarctions) 05/2007 - 12/2006
2	Renal Insufficiency (Renal Failure) 09/2006 - 07/2002
2	Bundle-Branch Block (Fascicular Block) 10/2004 - 03/2003
2	Closed Head Injuries 08/2003 - 11/2002
2	Craniocerebral Trauma (Head Injury) 08/2003 - 11/2002
1	Disease Progression 12/2020

Drug/Important Bio-Agent (IBA)

20	AnticoagulantsIBA 10/2020 - 11/2012
17	Heparin (Liquaemin)FDA LinkGeneric 03/2021 - 06/2006
14	Clopidogrel (Plavix)FDA Link 12/2020 - 01/2003
14	Dabigatran FDA Link 10/2019 - 11/2012
12	Glycoproteins (Glycoprotein)IBA 03/2012 - 07/2003
10	TroponinIBA 02/2020 - 07/2002
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2003
9	idarucizumabIBA 01/2019 - 07/2015
8	Vitamin K FDA Link 01/2020 - 08/2014
8	Enoxaparin (Lovenox)FDA LinkGeneric 01/2017 - 10/2006
7	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2006
7	Platelet Membrane Glycoprotein IIbIBA 08/2009 - 07/2003
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2016 - 06/2006
6	bivalirudin (Angiomax)FDA Link 08/2009 - 04/2008
5	otamixabanIBA 03/2021 - 12/2012
5	AntithrombinsIBA 09/2013 - 10/2006
4	Eptifibatide (Integrilin)FDA Link 03/2021 - 12/2012
4	TicagrelorIBA 12/2020 - 11/2010
4	Pharmaceutical PreparationsIBA 03/2016 - 10/2004
4	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 09/2013
4	RivaroxabanIBA 01/2016 - 11/2012
3	Oxygen (Dioxygen)IBA 02/2020 - 03/2003
3	trans-crotonin (CTN)IBA 02/2020 - 12/2006
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 09/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2012 - 08/2002
3	clevidipine FDA Link 04/2011 - 03/2009
2	Troleandomycin (TAO)FDA Link 03/2021 - 09/2013
2	Prasugrel Hydrochloride FDA Link 12/2020 - 02/2020
2	Complement System Proteins (Complement)IBA 09/2020 - 04/2009
2	Adenosine Diphosphate (ADP)IBA 02/2020 - 08/2009
2	prothrombin complex concentrates (PPSB)IBA 01/2020 - 08/2014
2	apixabanIBA 01/2018 - 09/2016
2	Purinergic P2Y Receptor AntagonistsIBA 06/2017 - 01/2003
2	Opioid Analgesics (Opioids)IBA 03/2016 - 10/2015
2	Analgesics (Analgesic Drugs)IBA 03/2016 - 01/2015
2	Hemoglobins (Hemoglobin)IBA 03/2014 - 06/2013
2	Factor Xa InhibitorsIBA 09/2013 - 05/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2010 - 07/2006
2	LipidsIBA 12/2010 - 07/2005
2	cangrelorIBA 12/2009 - 12/2009
2	Fondaparinux (Arixtra)FDA Link 06/2009 - 05/2008
2	helioxIBA 11/2008 - 03/2003
2	HeliumIBA 11/2008 - 03/2003
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2008 - 01/2004
2	Indicators and Reagents (Reagents)IBA 08/2007 - 01/2006
2	MB Form Creatine KinaseIBA 01/2006 - 01/2004
2	NexusIBA 08/2003 - 11/2002
2	Troponin T (Troponin T1)IBA 03/2003 - 07/2002
1	Blood Coagulation Factors (Coagulation Factor)IBA 10/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 09/2020
1	omega-Chloroacetophenone (Mace)IBA 02/2020

Therapy/Procedure

54	Therapeutics 01/2021 - 08/2002
17	Percutaneous Coronary Intervention 03/2021 - 03/2003
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2020 - 03/2003
4	Stents 12/2020 - 12/2009
3	Anticoagulation Reversal 10/2020 - 05/2017
3	Thrombolytic Therapy 01/2006 - 01/2004
2	Length of Stay 12/2020 - 11/2007
2	Electric Countershock (Cardioversion) 01/2018 - 09/2016
2	Analgesia 03/2016 - 01/2015
2	Catheters 06/2011 - 06/2009
2	Contraindications 05/2010 - 07/2005
1	Pain Management 01/2021
1	Secondary Prevention 01/2021
1	Extracorporeal Membrane Oxygenation 09/2020